Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morris Sherman

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
Plos One|July 19, 2012
Influence of socioeconomic status on survival of hepatocellular carcinoma in the Ontario population; a population-based study, 1990-2009Nathaniel Jembere, Michael A Campitelli, Morris Sherman, et al.
Annals of Hepatology|June 17, 2011
Is pre-treatment liver biopsy necessary for all hepatitis C genotypes?Kevork M Peltekian, Vincent G Bain, Samuel S Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 11, 2015
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE StudyJoong-Won Park, Minshan Chen, Massimo Colombo, et al.
Journal of Vascular and Interventional Radiology : JVIR|April 2, 2005
Needle tract seeding after radiofrequency ablation of hepatic tumorsJeffrey D Jaskolka, Murray R Asch, John R Kachura, et al.
Hepatology (Baltimore, Md.)|January 10, 2013
Health care costs associated with hepatocellular carcinoma: a population-based studyHla-Hla Thein, Wanrudee Isaranuwatchai, Michael A Campitelli, et al.
The Journal of Nutrition|February 13, 2009
Hepatic fatty acid composition differs between chronic hepatitis C patients with and without steatosisBianca M Arendt, Saira S Mohammed, Elaheh Aghdassi, et al.
Hepatology (Baltimore, Md.)|June 10, 2008
Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeksMorris Sherman, Cihan Yurdaydin, Halis Simsek, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 18, 2012
Health state utilities and quality of life in patients with hepatitis BGloria Woo, George Tomlinson, Colina Yim, et al.
Radiology|March 3, 2011
Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinomaTae Kyoung Kim, Kyoung Ho Lee, Hyun-Jung Jang, et al.
Annals of Hepatology|August 16, 2017
Wait Time for Curative Intent Radio Frequency Ablation is Associated with Increased Mortality in Patients with Early Stage Hepatocellular CarcinomaMayur Brahmania, Osman Ahmed, Melissa Kelley, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
Plos One|July 19, 2012
Influence of socioeconomic status on survival of hepatocellular carcinoma in the Ontario population; a population-based study, 1990-2009Nathaniel Jembere, Michael A Campitelli, Morris Sherman, et al.
Annals of Hepatology|June 17, 2011
Is pre-treatment liver biopsy necessary for all hepatitis C genotypes?Kevork M Peltekian, Vincent G Bain, Samuel S Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 11, 2015
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE StudyJoong-Won Park, Minshan Chen, Massimo Colombo, et al.
Journal of Vascular and Interventional Radiology : JVIR|April 2, 2005
Needle tract seeding after radiofrequency ablation of hepatic tumorsJeffrey D Jaskolka, Murray R Asch, John R Kachura, et al.
Hepatology (Baltimore, Md.)|January 10, 2013
Health care costs associated with hepatocellular carcinoma: a population-based studyHla-Hla Thein, Wanrudee Isaranuwatchai, Michael A Campitelli, et al.
The Journal of Nutrition|February 13, 2009
Hepatic fatty acid composition differs between chronic hepatitis C patients with and without steatosisBianca M Arendt, Saira S Mohammed, Elaheh Aghdassi, et al.
Hepatology (Baltimore, Md.)|June 10, 2008
Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeksMorris Sherman, Cihan Yurdaydin, Halis Simsek, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 18, 2012
Health state utilities and quality of life in patients with hepatitis BGloria Woo, George Tomlinson, Colina Yim, et al.
Radiology|March 3, 2011
Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinomaTae Kyoung Kim, Kyoung Ho Lee, Hyun-Jung Jang, et al.
Annals of Hepatology|August 16, 2017
Wait Time for Curative Intent Radio Frequency Ablation is Associated with Increased Mortality in Patients with Early Stage Hepatocellular CarcinomaMayur Brahmania, Osman Ahmed, Melissa Kelley, et al.
Pageof 16